Douglas G. Forsyth - 08 Sep 2026 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2026, 16:26:03 UTC
Prior SEC filing
18 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth

Key filing fact

Douglas G. Forsyth filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 08 Sep 2026.

Key facts

  • This page summarizes Douglas G. Forsyth's Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2026, 16:26.

Change

  • Previous filing in this sequence was filed on 18 Sep 2026.
  • Current net transaction value: +$286,617.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001240801 Primary reporting owner

FORSYTH DOUGLAS

Relationship
Director
Address
C/O INHIBRX BIOSCIENCES, INC., 11025 NORTH TORREY PINES ROAD, SUITE 140, LA JOLLA
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth
Signature date
08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBX transaction

Common Stock

Purchase

Transaction value
$286,617
Shares
+2,500
Change %
+1.1%
Price
$114.65
Shares after
227,064
Date
08 Sep 2026
Ownership
By the Forsyth Family Trust Dated July 20, 2001
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were purchased in multiple transactions at prices ranging from $114.36 to $114.689 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F2

The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .